In contrast to the pathway of integrin α6β1, integrin αv also has the tumor-initiation potential achieved by regulating the expression of Slug independently of FAK in basal breast CSCs (Desgrosellier et al., 2014). The gene discussed is PTK2; the disease is neoplasm.